2,5-Dibutoxyterephthalohydrazide

Catalog No. :
ACRDHM248
CAS No. :
1136292-72-2
Molecular Formula :
C16H26N4O4
Molecular Weight :
338.41

IUPAC Name:2,5-dibutoxyterephthalohydrazide

2,5-Dibutoxyterephthalohydrazide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$70.00Login to see priceIn stockIn stock
5g97%$248.00Login to see priceIn stockIn stock
10g97%$449.00Login to see priceIn stockIn stock
25g97%$1099.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,5-Dibutoxyterephthalohydrazide
IUPAC Name2,5-dibutoxyterephthalohydrazide
MDL No.MFCD34179508
Molecular FormulaC16H26N4O4
Molecular Weight338.41
SMILESO=C(NN)C1=CC(OCCCC)=C(C=C1OCCCC)C(=O)NN
InChI KeyPQAHUXXAKNMYDE-UHFFFAOYSA-N
Synonym1,4-Benzenedicarboxylic acid, 2,5-dibutoxy-, 1,4-dihydrazide;2,5-dibutoxyterephthalohydrazide;1,4-Benzenedicarboxylic acid, 2,5-dibutoxy-, 1,4-dihydrazide ISO 9001:2015 REACH;2,5-Dibutoxy-1,4-benzenedicarboxylic acid 1,4-dihydrazide;1,4-BenzenedicarboxylicN/Aacid,N/A2,5-dibutoxy-,N/A1,4-dihydrazide
CAS No.1136292-72-2
PubChem CID154634190

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACRDHM248 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRDHM248 route product structure diagram
    ACRDHM2481136292-72-2 In Stock
Inquiry

2. ACRDHM248 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRDHM248 route product structure diagram
    ACRDHM2481136292-72-2 In Stock
Inquiry

Comments (0)